' Throughout the world, there are approximately 150 million clinical cases (of malaria) annually. In tropical Africa alone, where malaria affects practically the entire population, it has been estimated that every year the disease causes the death of one million children under the age of 14 years. . . . Sleeping sickness (African trypanosomiasis) constitutes a permanent and serious risk to the health and wellbeing of at least 35 million people, and animal trypanosomiasis is the main obstacle to the development of the vast potential for livestock development in the (African) continent.. . . Millions of people on the American continents suffer and many die from Chagas' disease, hampering socioeconomic development of the affected areas.' World Health Organisation Documentation (TDRI W P 76.6 & 76.12) for the Special Programme for Research and Training in Tropical Diseases, Geneva, 1976. long obscured the true perspective of protozoal diseases.
Although plasmodia and trypanosoma are the pre-eminent protozoal pathogens, leishmania, toxoplasma and others represent serious health hazards to millions of people. Furthermore, protozoal diseases probably constitute less than half of the total threat from pathogenic parasites. Many helminth infections, however, are chronic and debilitating whereas malaria and trypanosomiasis may strike rapidly and fatally. Inattention to the study of protozoal diseases can be attributed partly to technical difficulties and partly to the fact that protozoal diseases are largely the problem of what is fashionably called the Third World. I have no wish to comment on the socioeconomic, sociopolitical and politicoscientific aspects of the situation, except to welcome the current surge of scientific enthusiasm and activity in the area of parasitic diseases.
The possibility of a malaria vaccine is frequently and optimistically discussed, but the prospect of immunization against African trypanosomiasis appears remote. Paradoxically, trypanosomes have been the subject of more advanced scientific study than malarial parasites. This is due largely to the relative ease with which certain trypanosomes and their non-pathogenic cousins (especially Crithidia) may be handled in the laboratory and produced on a large scale. The key to the paradox lies in the phenomenon of antigenic variation. 
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The archetypal African trypanosome
The trypanosoma and members of related genera form a ubiquitous group of unicellular spindle-shaped parasitic protozoa characterized by four principal structural features : a single flagellum, a complex microtubular skeleton underlying the plasma membrane, a single but often highly branched mitochondrion and an unusually structured mass of mitochondria1 DNA -the so-called kinetoplast DNA. There are several species responsible for the various forms of animal and human trypanosomiasis (' sleeping sickness') in Africa. In contrast to the South American form of trypanosomiasis (Chagas' disease), where the causative agent (Trypanosoma cruzi) multiplies inside the cells of its human host, the African trypanosomes have no known intracellular stage. They multiply by binary fission in the vascular system and tissue interstices and are not known to have any sexual stage in their life cycle. Transmission of African trypanosomes from one mammalian host to another is mediated principally by members of the genus Glossina (tsetse). Other bloodsucking insects may be implicated as vectors in some circumstances. It is generally believed that many animals in the wild have adapted to tolerate trypanosome infections without overt pathological complications. These animals constitute a reservoir of infection to which most domestic livestock are highly susceptible. Trypanosomiasis is a severe veterinary problem affecting around four million square miles of Africa. The three species primarily responsible are Trypanosoma congolense, T. vivax and T. brucei.
Human trypanosomiasis is much less prevalent than the animal disease but nevertheless constitutes a serious health risk in some areas. The names of the causative agents, T. rhodesiense and T. gambiense reflect the apparent geographical dominance of acute and chronic trypanosomiasis in East and West Africa, respectively. Trypanosoma rhodesiense and T. gambiense cannot be distinguished with certainty from T. brucei. It is not known whether or not the ability of any isolate of a member of the so-called T. brucei subgroup to infect humans is a stable characteristic or whether it is related to variant surface antigen (see below) expression. Isolates which are unable to infect humans appear to be lysed by normal human serum and high density lipoprotein has recently been implicated as the lytic agent (Rifkin, 1978) . Until the basis for host specificity or an entirely reliable differential test can be established, animal trypanosomes of the brucei type must be regarded as potentially pathogenic to humans. Despite this caveat, some clones of brucei type trypanosomes have been handled in laboratories for many years without incident and might therefore be considered to present a lower risk to the experimenter than less familiar clones. This is fortunate as, for the biochemist, T. brucei has two main advantages over the purely animal-infective T. congolense and T. vivax. After 3 d infection, many isolates of T. brucei may account for 30 % of the packed cell volume in the blood of a rat or mouse. Furthermore, due to charge differences, T. brucei may be rapidly and completely separated from all host blood cells, using a column of DEAE-cellulose (Lanham, 1968 ; Lanham & Godfrey, 1970) . Cloning is permitted by the ability of a single trypanosome to infect a mouse.
More natural trypanosome infections may run for several months and are often characterized by distinct waves of parasitaemia in which successive parasite populations differ antigenically. Antigenic variation appears to be the primary mechanism for parasite survival in an immunocompetent host. It appears that antigenic variation can be largely, if not entirely, explained by the sequential expression of alternative surface glycoproteins. The repertoire of alternative glycoproteins which may be expressed by a single trypanosome or a trypanosome species is yet unknown, as is the genetic basis of antigenic variation. Although the phenomenon has been most extensively studied in T. brucei, antigenic variation seems to be a feature of all the pathogenic African trypanosomes.
Antigenic variation has attracted much interest and for this reason the somewhat inadequate experimental data has been excessively reviewed in recent years (Vickerman, 1971 (Vickerman, , 1974 Gray & Luckins, 1976; Doyle, 1977; Cross, 1978) . There is little new that can presently be said with certainty about the biochemistry of variant antigens.
Variant antigens identijied
The entire external surface of the African trypanosome in its bloodstream stage is enveloped by a compact and regular electron-dense surface coat, 12 to 15 nm in depth, first described in detail by Vickerman (1969) . The coat is absent from developmental stages found in the midgut of the tsetse vector. For some time following ingestion of trypanosomes by the tsetse, they are not transmissible. After a period of multiplication in the midgut, trypanosomes invade the salivary gland where the surface coat and virulence to the mammalian host are simultaneously reacquired in the ' metacyclic ' forms.
Despite the efforts of earlier workers, the purification of homogeneous surface antigens from T. brucei was only recently achieved (Cross, 1975) . The surface coat of each antigenically distinct trypanosome appears to consist largely, if not entirely, of a single characteristic species of glycoprotein. Following mechanical disruption of cells, variant surface glycoproteins are largely released in soluble form and may easily be purified in high yield (Cross, 1975 (Cross, , 1977a . The purified glycoproteins contain a single polypeptide chain of 65 000 apparent molecular weight on sodium dodecyl sulphate-polyacrylamide gels. The area of the trypanosome cell surface was experimentally estimated to be similar to that of an erythrocyte, suggesting that a 65 000 molecular weight glycoprotein which comprises 7 to 10% of the total cell protein (7 x lo6 to 10 x lo6 molecules of glycoprotein per cell) could form a closely packed monolayer covering the entire trypanosome surface. We do not know for certain that the coat is a monolayer: this idea forms the simplest working hypothesis so long as there is no conflicting evidence. The mode of attachment of the variant glycoproteins to the trypanosome surface remains to be elucidated. Although the variant glycoproteins appear to be loosely bound, the possibility that they are released by proteolytic cleavage of a larger molecule which penetrates the lipid bilayer cannot yet be eliminated. Indeed, this possibility is encouraged by the apparent susceptibility of the carboxy terminus to proteolytic degradation (Johnson & Cross, 1979) and the marked heterogeneity of variant glycoprotein antigens found by other workers (see references in Cross, 1978) , which is probably attributable to proteolytic degradation.
Variant glycoproteins isolated from T. brucei have characteristic isoelectric points, amino acid and carbohydrate compositions (Table 1) (Cross, 1977a, b ; Johnson & Cross, 1977) . The carbohydrate component differs between variants, both in total amount (7 to 1774, by weight), in its location on the polypeptide backbone and in the proportion of the four sugar constituents : galactose, glucose, mannose and N-acetylglucosamine. The immunological uniqueness of each variant glycoprotein appears to be a reflection of immense amino acid sequence diversity. Sequence variation occurs throughout the polypeptide chain, as indicated by the mapping of cyanogen bromide and enzymic cleavage products, but whether variation elsewhere is as extensive as is found at the amino terminus ( Fig. 1 ) will shortly be revealed by ongoing sequencing projects. Several groups are currently involved in attempts to 'clone' the variant glycoprotein genes, using in vitro DNA recombination techniques. This approach should resolve the key questions concerning the genetic mechanisms for the generation of glycoprotein diversity.
It might be unwise to overemphasize the sequence diversity which is apparent in the small number of variant antigens so far studied. Technical reasons may have led us, in the early stages of this work, to select a small spectrum of glycoproteins which differ more extensively than would a random sample taken from the entire repertoire of variants which any trypanosome clone is capable of expressing.
The variant surface antigens of other African trypanosomes have been characterized to a lesser degree. My own preliminary experiments with a clone of diskinetoplastic T. evansi showed very different results from T. brucei (Cross, 1977a) . Purified glycoprotein run on sodium dodecyl sulphate-polyacrylamide gels under non-reducing conditions showed a single component of 96 000 apparent molecular weight. Reducing conditions yielded a major band at either 65000 or 45000 molecular weight, depending on the fraction separated Bridgen et al., 1976, and Cross, 1979.) by isoelectric focusing. There are several possible interpretations of these gel patterns and further work will be necessary to determine whether the variant surface glycoprotein of T. evansi has a multichain structure or is a large single polypeptide. Identification and characterization of the surface coat components of T. congolense has been reported by two laboratories. Reinwald et al. (1978) used 35S-labelIed diazotized sulphanilic acid to identify the major surface component of T. congolense. Most of the label was recovered in a 57000 molecular weight component, with a small amount of a secondary component of 50 000 molecular weight. Using lactoperoxidase-catalysed 1251 iodination or galactose oxidase oxidation followed by NaB3H4 reduction, Rovis et al. (1978) identified a 56000 molecular weight glycoprotein with no evidence for multiple polypeptide chains. The glycoprotein preparation from a trypanosome clone which was homogeneous by immunofluorescence criteria showed three components differing in isoelectric point. The authors felt the most likely expIanation for charge heterogeneity was Baltz et al. (1976) have isolated glycoprotein antigens from T. equiperdum using affinity chromatography of soluble extracts on Concanavalin A-Sepharose. The molecular weight of the single glycoprotein band obtained from two clones was the same as that reported for T. brucei (65000), but the glycoprotein from a third clone appeared to exist as a dimer when gels were run under non-reducing conditions. A portion of the glycoprotein could not be eluted from the affinity column unless 0.2% Triton detergent was included in the eluant. Preliminary analysis showed that each clone-specific glycoprotein fraction contained four to seven components of different isoelectric points. The authors attributed this microheterogeneity to minor modifications in the (polypeptide) interior of each molecule. I feel that minor proteolytic degradation is a more likely explanation. Amino acid analyses and N-terminal sequencing of several T. equiperdum variant glycoproteins showed variability of a similar degree to that found in T. brucei, but sugar analyses seemed to indicate the presence of a constant carbohydrate chain (Baltz et al., 1977) .
As yet, no characterization of the variant surface antigens of 7". vivax has been reported. It would be interesting to determine whether different trypanosome species have common segments of amino acid sequences in their variant antigens. Such observations could clarify the evolutionary relationships of trypanosome species. No surface antigens other than the variant antigens have been biochemically characterized in any species of African trypanosome and knowledge of the integral proteins of the plasma membrane is minimal.
Common structural features
Despite the amino acid sequence diversity indicated by our preliminary structural studies, we might anticipate some degree of sequence conservation. Variant glycoproteins must presumably have evolved as distinct structural genes by processes of gene duplication and mutation, or be formed by splicing of shared genetic elements. The primary role of the surface coat may be nothing more than to act as a disposable physical screen, preventing potentially lethal components of the host's protective mechanisms from damaging the underlying plasma membrane (Cross & Johnson, 1976 ; Cross, 1978) . Requirements for secretion and arrangement of glycoprotein molecules to form the surface coat might be expected to limit the possibilities for variation, particularly in three-dimensional structure. In order for each variant glycoprotein to be antigenically unique, it would not need to have a totally distinct amino acid sequence.
These considerations led us to try the approach of selective cleavage to determine whether distinct structural and functional domains could be distinguished in variant glycoproteins. Undenatured proteins may be relatively resistant to proteolysis, and the native conformation may selectively expose specific regions that are susceptible to enzyme cleavage. Exploitation of this concept was conspicuously successful in distinguishing functional domains in the immunoglobulins (Porter, 1973) . The results with variant glycoproteins were not so striking as with immunoglobulins! However, a common feature of the six variant glycoproteins examined was a cleavage pattern with trypsin that suggested that the N-terminal twothirds and the C-terminal one-third of the polypeptide folded to form two distinct and independent domains (Johnson & Cross, 1979) .
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In a brief series of initial experiments, native variant glycoproteins were treated with several concentrations of Pronase, trypsin, chymotrypsin, papain and pepsin under appropriate conditions. Only trypsin showed a clearly controlled effect which encouraged further study. Within 5 min, the native glycoproteins were cleaved yielding a large Nterminal fragment (48000 to 55000 molecular weight, depending on the variant) together with one or more smaller C-terminal fragments. After 30 to 60 min incubation, further breakdown of the large fragment occurred in some variants. The final large fragment (40000 to 52000 molecular weight) was resistant to further trypsin cleavage for at least 16 h. The characteristic products of trypsin cleavage are summarized in Fig. 2 . In four cases it was proven by N-terminal sequence analysis that the large fragment represented the N-terminus of the intact antigen. The smaller C-terminal fragments have not been characterized in detail. From their varied compositions, it is clear that they cannot have an entirely common sequence. The possible existence of homology in this region is being examined by detailed sequence studies. ' Fingerprinting ' evidence alone was inconclusive.
No common features were consistently associated with each of the cleavage domains. Carbohydrate segregated preferentially into the C-terminal domain, except in variant 99 which contains the highest amount of carbohydrate (17%, by weight) of any variant glycoprotein examined. In variants 49 and 52, which contain the lowest amounts of carbohydrate (four glucosamine residues per molecule), it is all located in the C-terminal peptides. This fact was exploited in other studies of variant 52 (Cross & Johnson, 1976) to deduce the orientation of variant glycoprotein on the cell surface. Observations of Concanavalin A binding to the trypanosome surface, before and after treatment of living cells with trypsin, suggested that, in this variant, the carbohydrate is located in the inner region of the surface coat, suggesting that the C-terminal region of the polypeptide interacts with the plasma membrane and the N-terminal region is outermost. Thus the distinction between the N-and C-terminal domains, which dissociate without the use of denaturing conditions or thiol reagents, may be significant in relation to the organization and function of the variant glycoproteins on the trypanosome surface.
Immunological cross-reactivity
In experiments performed shortly after the initial successful purification of a small number of variant glycoproteins (Cross, 1975) , antisera appeared to react uniquely with the corresponding glycoprotein (as judged by double immunodiffusion and radioimmunoassays) or living trypanosomes (as observed by an indirect fluorescence test). The extent of the immunological cross-reactions subsequently demonstrated using radioimmunoassay (Barbet & McGuire, 1978) was rather surprising although, at the same time, Dr Frans van Knapen (Rijks Institut voor de Volksgezondheid, Bilthoven, The Netherlands) and I had observed, by enzyme-linked immunoabsorbent assays (ELTSA), extensive cross-reactions between two purified variant glycoproteins and a wide range of antisera to different trypanosome species. Figure 3 shows the extent of cross-reactivity of each antigen with two dilutions of antisera to the purified variant glycoproteins and antisera from rabbits infected with T. brucei, T. rhodesiense, T. gambiense, T. congolense and T. vivax. Several of the variant glycoproteins examined by Barbet & McGuire (1978) originated from clones I had previously prepared and studied. I have therefore re-examined several glycoproteins and their corresponding antisera by radioimmunoassay. Figure 4 (a to d ) shows the precipitation of four purified variant glycoproteins by antisera raised against seven purified glycoproteins. The extent of heterologous precipitation observed in these experiments was more variable and considerably less than that reported by Barbet & McGuire. Fresh antisera raised against three antigens (55, 121 and 221) in eleven rabbits, including seven rabbits immunized by the protocol used by Barbet & McGuire, gave essentially similar results. An exchange of antisera between our laboratories confirmed that 
(from 59 000) Fig. 2 . Polypeptide fragments arising from tryptic cleavage of six native variant glycoproteins (Johnson & Cross, 1979) . The symbols f48 etc., denote 'fragment 48000 molecular weight' etc.; VSG denotes variant surface glycoprotein. The asterisks indicate fragments which were sequenced at the N-termini. Variant 221 had an initial molecular weight of only 59000. our antisera had much lower or zero cross-reacting activities against antigens iodinated in Nairobi, but Nairobi antisera of four heterologous specificities were all of approximately equal and high efficiency in precipitating antigens 55 and 221 (50% precipitation of 10 ng antigen at serum dilutions of 100-to 1000-fold) in my laboratory. This suggests that variation between the responses of individual rabbits may determine the extent of cross-reacting antibody production. Antisera from immunized mice and bovines apparently do not precipitate heterologous antigens (A. 0, Homologous antisera; , heterologous antisera. Antigens were labelled by the chloramine-T method to a specific activity between 1000 and 10 000 c.p.m. ng-l. Antisera were raised in 2 to 4 kg New Zealand White rabbits by primary subcutaneous injection at four sites of a total of 1 mg purified VSG in an emulsion of 0.2 ml saline and 0.2 ml Freunds complete adjuvant. Two further subcutaneous injections of 0.5 to 1 mg VSG in saline were given at 10 d intervals. Sera were obtained 7 to 10 d after the third or subsequent injections of antigen and were lyophilized and stored under nitrogen at -20°C. Radioimmunoassay was performed by incubating (2 h at 37°C in a total volume of 0.065 ml phosphate-buffered saline containing 4 mg bovine albumin ml-l) 1 ng antigen with antisera dilutions prepared in appropriate dilutions of normal rabbit serum to maintain a constant amount of rabbit serum in each assay. Antigen-antibody complexes were precipitated with goat anti-rabbit IgG (Miles) and counted. Antiserum dilution is plotted against the percentage of bound antigen, after correction for non-specific binding, taking the maximal precipitation by homologous antiserum as the 100 yo value. taining whether the cross-reacting determinants were localized in one region of the molecule. Large undenatured N-terminal tryptic fragments of molecular weights 52000, 41 000 and 44 000 were purified from variant glycoproteins 55, 121 and 221, respectively, and iodinated. The results (Fig. 4 e to g ) show that the tryptic fragments from variant glycoproteins 55 and 121 were efficiently precipitated by homologous antisera from rabbits immunized with either the corresponding fragment or the intact glycoprotein. The fragment from glycoprotein 221 was efficiently precipitated by antiserum against intact glycoprotein 22 l . There was no precipitation of any of the three N-terminal fragments by any heterologous antisera tested. Additionally, antisera raised against the N-terminal fragments of glycoproteins 55 and 12 1 were unable to precipitate intact heterologous glycoproteins. A glycopeptide fragment representing the C-terminal 17 000 molecular weight initial cleavage product of variant 121 (equivalent to variant 52 in Fig. 2 ) was an efficient inhibitor of heterologous immunoprecipitation of variant 55 by heterologous antisera 121 and 221 and was itself shown to be precipitable by several heterologous antisera.
It has already been noted that all the carbohydrate of glycoprotein 121 (52) and most of the carbohydrate of glycoprotein 55 is located in the C-terminal region. This is not true for glycoprotein 221, where the large N-terminal fragment which is not precipitable by heterologous antisera is retained on Concanavalin A-Sepharose. The question of whether the cross-reactions are due to a carbohydrate determinant or a conserved peptide determinant has not yet been resolved.
The results of the precipitation of glycoprotein 55 by antiserum 221 in the absence or presence of various unlabelled competitor glycoproteins (Fig. 5) imply that the crossreacting determinants are not identical in each glycoprotein. The upper curve (0) shows the precipitation of 4 ng iodinated glycoprotein 55: the lower curve (a) shows the precipitation of 132 ng iodinated glycoprotein 55. In the presence of a 33-fold excess of an unlabelled glycoprotein, the percentage binding curve for 4 ng. iodinated glycoprotein will follow the lower curve (a) if the cross-reacting determinants have identical affinities and the upper curve if there is no identity. The latter appears to be likely for glycoprotein 11 8, whereas 117 shows partial similarity. In parallel experiments, the binding curves in the presence of unlabelled glycoproteins 55, 121 and 221 were coincident with the lower curve, suggesting complete identity. Other competition experiments (Cross, 1979) supported the observation that glycoprotein 1 18 shows low cross-reactivity.
With the possible exception of glycoprotein 118, the C-terminus of the native antigens appears to be very susceptible to proteolytic degradation, presumably because it is rather loosely folded. We must therefore consider the possibility that slight denaturation may expose common antigenic determinants which are normally masked by the native configuration of the polypeptide. It is well known that native and denatured proteins have different antigenic specificities. Therefore, cross-reactions may indicate sequence conservation in some regions of the polypeptide, which is unsurprising, and have little relevance to the antigenicity of the native antigen in situ. The significance of cross-reactivity will be clarified by further immunochemical and structural studies of a wider range of variant antigens.
Conclusion The main aim of my studies has been to relate glycoprotein structure to antigenic specificity and to probe the genetic basis of antigenic diversity. Some aspects of the equally important question of how the expression of alternative antigens is controlled have been discussed elsewhere (Cross, 1978; Vickerman, 1978) . Current interest in the control of antigenic variation is focussed on two questions. First, is the sequence of glycoprotein expression constant within one trypanosome clone? Secondly, how is variation instigated and what is the role of the immune response?
For many years it was only possible to cultivate, in vitro at 25"C, a form of T. brucei which seemed analogous to that which multiplies in the midgut of the insect vector. Variant glycoproteins are not expressed by these culture or midgut forms. Although the variant glycoproteins are reacquired in the ' metacyclic ' forms which differentiate in the insect salivary glands prior to reinfection of the mammalian hosts, it has not been possible to consistently reproduce this switch in culture. Recent work has led to the in vitro cultivation of bloodstream trypanosomes (Hirumi et al., 1977) and thereby removed the major remaining obstacle to the study of antigenic variation. The availability of a culture system and the application of recombinant DNA techniques should, together, allow the mechanisms of antigenic variation to be finally resolved.
I should like to express thanks to all those who have contributed to this work in many varied ways. 
